181 related articles for article (PubMed ID: 16356512)
1. Myosin phosphatase isoform switching in vascular smooth muscle development.
Payne MC; Zhang HY; Prosdocimo T; Joyce KM; Koga Y; Ikebe M; Fisher SA
J Mol Cell Cardiol; 2006 Feb; 40(2):274-82. PubMed ID: 16356512
[TBL] [Abstract][Full Text] [Related]
2. Conditioning effect of blood flow on resistance artery smooth muscle myosin phosphatase.
Zhang H; Fisher SA
Circ Res; 2007 Mar; 100(5):730-7. PubMed ID: 17293476
[TBL] [Abstract][Full Text] [Related]
3. Dynamic changes in expression of myosin phosphatase in a model of portal hypertension.
Payne MC; Zhang HY; Shirasawa Y; Koga Y; Ikebe M; Benoit JN; Fisher SA
Am J Physiol Heart Circ Physiol; 2004 May; 286(5):H1801-10. PubMed ID: 14704233
[TBL] [Abstract][Full Text] [Related]
4. Captopril prevents myosin light chain phosphatase isoform switching to preserve normal cGMP-mediated vasodilatation.
Chen FC; Ogut O; Rhee AY; Hoit BD; Brozovich FV
J Mol Cell Cardiol; 2006 Sep; 41(3):488-95. PubMed ID: 16815432
[TBL] [Abstract][Full Text] [Related]
5. Vascular reactivity in heart failure: role of myosin light chain phosphatase.
Karim SM; Rhee AY; Given AM; Faulx MD; Hoit BD; Brozovich FV
Circ Res; 2004 Sep; 95(6):612-8. PubMed ID: 15321927
[TBL] [Abstract][Full Text] [Related]
6. Redox signaling and splicing dependent change in myosin phosphatase underlie early versus late changes in NO vasodilator reserve in a mouse LPS model of sepsis.
Reho JJ; Zheng X; Asico LD; Fisher SA
Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1039-50. PubMed ID: 25724497
[TBL] [Abstract][Full Text] [Related]
7. Essential role for class II phosphoinositide 3-kinase alpha-isoform in Ca2+-induced, Rho- and Rho kinase-dependent regulation of myosin phosphatase and contraction in isolated vascular smooth muscle cells.
Yoshioka K; Sugimoto N; Takuwa N; Takuwa Y
Mol Pharmacol; 2007 Mar; 71(3):912-20. PubMed ID: 17179444
[TBL] [Abstract][Full Text] [Related]
8. Spontaneously tonic smooth muscle has characteristically higher levels of RhoA/ROK compared with the phasic smooth muscle.
Patel CA; Rattan S
Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G830-7. PubMed ID: 16763289
[TBL] [Abstract][Full Text] [Related]
9. Characterization and function of MYPT2, a target subunit of myosin phosphatase in heart.
Okamoto R; Kato T; Mizoguchi A; Takahashi N; Nakakuki T; Mizutani H; Isaka N; Imanaka-Yoshida K; Kaibuchi K; Lu Z; Mabuchi K; Tao T; Hartshorne DJ; Nakano T; Ito M
Cell Signal; 2006 Sep; 18(9):1408-16. PubMed ID: 16431080
[TBL] [Abstract][Full Text] [Related]
10. Role of myosin phosphatase isoforms in cGMP-mediated smooth muscle relaxation.
Khatri JJ; Joyce KM; Brozovich FV; Fisher SA
J Biol Chem; 2001 Oct; 276(40):37250-7. PubMed ID: 11486008
[TBL] [Abstract][Full Text] [Related]
11. MYPT1 protein isoforms are differentially phosphorylated by protein kinase G.
Yuen S; Ogut O; Brozovich FV
J Biol Chem; 2011 Oct; 286(43):37274-9. PubMed ID: 21890627
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiles of vascular smooth muscle show differential expression of mitogen-activated protein kinase pathways during captopril therapy of heart failure.
Chen FC; Brozovich FV
J Vasc Res; 2008; 45(5):445-54. PubMed ID: 18418003
[TBL] [Abstract][Full Text] [Related]
13. The involvement of phosphorylation of myosin phosphatase targeting subunit 1 (MYPT1) and MYPT1 isoform expression in NO/cGMP mediated differential vasoregulation of cerebral arteries compared to systemic arteries.
Lubomirov LT; Papadopoulos S; Filipova D; Baransi S; Todorović D; Lake P; Metzler D; Hilsdorf S; Schubert R; Schroeter MM; Pfitzer G
Acta Physiol (Oxf); 2018 Sep; 224(1):e13079. PubMed ID: 29694711
[TBL] [Abstract][Full Text] [Related]
14. Ca2+-independent, inhibitory effects of cyclic adenosine 5'-monophosphate on Ca2+ regulation of phosphoinositide 3-kinase C2alpha, Rho, and myosin phosphatase in vascular smooth muscle.
Azam MA; Yoshioka K; Ohkura S; Takuwa N; Sugimoto N; Sato K; Takuwa Y
J Pharmacol Exp Ther; 2007 Feb; 320(2):907-16. PubMed ID: 17110524
[TBL] [Abstract][Full Text] [Related]
15. Tra2β protein is required for tissue-specific splicing of a smooth muscle myosin phosphatase targeting subunit alternative exon.
Fu K; Mende Y; Bhetwal BP; Baker S; Perrino BA; Wirth B; Fisher SA
J Biol Chem; 2012 May; 287(20):16575-85. PubMed ID: 22437831
[TBL] [Abstract][Full Text] [Related]
16. A myosin phosphatase targeting subunit isoform transition defines a smooth muscle developmental phenotypic switch.
Dirksen WP; Vladic F; Fisher SA
Am J Physiol Cell Physiol; 2000 Mar; 278(3):C589-600. PubMed ID: 10712248
[TBL] [Abstract][Full Text] [Related]
17. TRA2β controls Mypt1 exon 24 splicing in the developmental maturation of mouse mesenteric artery smooth muscle.
Zheng X; Reho JJ; Wirth B; Fisher SA
Am J Physiol Cell Physiol; 2015 Feb; 308(4):C289-96. PubMed ID: 25428883
[TBL] [Abstract][Full Text] [Related]
18. Tissue-specific expression of myosin phosphatase subunits and isoforms in smooth muscle of mice and humans.
Oslin K; Reho JJ; Lu Y; Khanal S; Kenchegowda D; Prior SJ; Fisher SA
Am J Physiol Regul Integr Comp Physiol; 2022 Apr; 322(4):R281-R291. PubMed ID: 35107022
[TBL] [Abstract][Full Text] [Related]
19. Unzipping the role of myosin light chain phosphatase in smooth muscle cell relaxation.
Huang QQ; Fisher SA; Brozovich FV
J Biol Chem; 2004 Jan; 279(1):597-603. PubMed ID: 14530290
[TBL] [Abstract][Full Text] [Related]
20. Myosin phosphatase isoforms as determinants of smooth muscle contractile function and calcium sensitivity of force production.
Dippold RP; Fisher SA
Microcirculation; 2014 Apr; 21(3):239-48. PubMed ID: 24112301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
